Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

253500 Denbufylline

253500
  
Purchase on Sigma-Aldrich

Overview

Replacement Information

Key Spec Table

CAS #Empirical Formula
57076-71-8C₁₆H₂₄N₄O₃
Description
Overview

This product has been discontinued.





A cell-permeable xanthine derivative that acts as a selective inhibitor of phosphodiesterase IV (PDE IV; Ki = ~ 1 µM). Possesses bronchodilatory properties. Displays negative inotropic effect by acting on a verapamil-sensitive site of the calcium channel in guinea pig ventricle papillary muscle independently of its PDE inhibitory activity.
Catalogue Number253500
Brand Family Calbiochem®
Synonyms1,3-Di-n-butyl-7-(2ʹ-oxopropyl)xanthine
References
ReferencesKumari, M., et al. 1997. Br. J. Pharmacol. 121, 459.
Sanae, F., et al. 1996. J. Pharmacol. Exp. Ther. 277, 54.
Cortijo, J., et al. 1993. Br. J. Pharmacol. 108, 562.
Nicholson, C.D., et al. 1989. Br. J. Pharmacol. 97, 889.
Product Information
CAS number57076-71-8
ATP CompetitiveN
FormWhite solid
Hill FormulaC₁₆H₂₄N₄O₃
Chemical formulaC₁₆H₂₄N₄O₃
ReversibleN
Structure formula ImageStructure formula Image
Applications
Biological Information
Primary TargetPhosphodiesterase IV (PDE IV)
Primary Target K<sub>i</sub>~ 1 µM against PDE IV
Purity≥97% by HPLC
Physicochemical Information
Cell permeableY
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
RTECSUO8413435
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Standard Handling
Storage +2°C to +8°C
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 months at -20°C.
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
253500 0

Documentation

Denbufylline MSDS

Title

Safety Data Sheet (SDS) 

Denbufylline Certificates of Analysis

TitleLot Number
253500

References

Reference overview
Kumari, M., et al. 1997. Br. J. Pharmacol. 121, 459.
Sanae, F., et al. 1996. J. Pharmacol. Exp. Ther. 277, 54.
Cortijo, J., et al. 1993. Br. J. Pharmacol. 108, 562.
Nicholson, C.D., et al. 1989. Br. J. Pharmacol. 97, 889.

Brochure

Title
Activators and Inhibitors of Adenylate Cyclase Technical Bulletin
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision30-April-2008 RFH
Synonyms1,3-Di-n-butyl-7-(2ʹ-oxopropyl)xanthine
DescriptionA cell-permeable xanthine derivative that acts as a selective inhibitor of phosphodiesterase IV (PDE IV; Ki ~1 µM). Possesses bronchodilatory activity. Displays negative ionotropic effect by acting on a verapamil-sensitive site of the calcium channel in guinea pig ventricle papillary muscle independently of its PDE inhibitory activity.
FormWhite solid
CAS number57076-71-8
RTECSUO8413435
Chemical formulaC₁₆H₂₄N₄O₃
Structure formulaStructure formula
Purity≥97% by HPLC
SolubilityDMSO (10 mg/ml) or Methanol (100 mg/ml)
Storage +2°C to +8°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 months at -20°C.
Toxicity Standard Handling
ReferencesKumari, M., et al. 1997. Br. J. Pharmacol. 121, 459.
Sanae, F., et al. 1996. J. Pharmacol. Exp. Ther. 277, 54.
Cortijo, J., et al. 1993. Br. J. Pharmacol. 108, 562.
Nicholson, C.D., et al. 1989. Br. J. Pharmacol. 97, 889.